Get the latest Science News and Discoveries

Phase 1 study supports recommended phase 3 dose for investigational EGFR x HER3 antibody-drug conjugate in EGFR-mutated lung cancer


None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of phase

phase

Photo of dose

dose

Photo of drug conjugate

drug conjugate

Related news:

News photo

Dose once, treat forever: drugs are being engineered to last much longer

News photo

Dose-dependent effects of cannabis edibles on simulated driving performance

News photo

NASA Awards First Prize in Phase 2 of Agency’s LunaRecycle Challenge